[go: up one dir, main page]

WO2006037050A3 - Procedes pour traiter l'insuffisance cardiaque congestive - Google Patents

Procedes pour traiter l'insuffisance cardiaque congestive Download PDF

Info

Publication number
WO2006037050A3
WO2006037050A3 PCT/US2005/034846 US2005034846W WO2006037050A3 WO 2006037050 A3 WO2006037050 A3 WO 2006037050A3 US 2005034846 W US2005034846 W US 2005034846W WO 2006037050 A3 WO2006037050 A3 WO 2006037050A3
Authority
WO
WIPO (PCT)
Prior art keywords
heart failure
congestive heart
methods
treating congestive
treating
Prior art date
Application number
PCT/US2005/034846
Other languages
English (en)
Other versions
WO2006037050A2 (fr
Inventor
Daniela Salvemini
Yingjie Chen
Original Assignee
Metaphore Pharmaceuticals Inc
Univ Minnesota
Daniela Salvemini
Yingjie Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metaphore Pharmaceuticals Inc, Univ Minnesota, Daniela Salvemini, Yingjie Chen filed Critical Metaphore Pharmaceuticals Inc
Publication of WO2006037050A2 publication Critical patent/WO2006037050A2/fr
Publication of WO2006037050A3 publication Critical patent/WO2006037050A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un procédé pour traiter l'insuffisance cardiaque congestive par l'administration d'une quantité thérapeutiquement efficace d'un mimétique de dismutase de superoxyde ou d'un catalyseur de décomposition de la péroxynitrite.
PCT/US2005/034846 2004-09-24 2005-09-26 Procedes pour traiter l'insuffisance cardiaque congestive WO2006037050A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61303904P 2004-09-24 2004-09-24
US60/613,039 2004-09-24

Publications (2)

Publication Number Publication Date
WO2006037050A2 WO2006037050A2 (fr) 2006-04-06
WO2006037050A3 true WO2006037050A3 (fr) 2006-06-01

Family

ID=36119572

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/034846 WO2006037050A2 (fr) 2004-09-24 2005-09-26 Procedes pour traiter l'insuffisance cardiaque congestive

Country Status (1)

Country Link
WO (1) WO2006037050A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2192899B1 (fr) * 2007-08-28 2014-10-01 Technion Research and Development Foundation, Ltd. Complexes de métaux de transition de corroles permettant de prévenir des troubles ou des maladies cardiovasculaires

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976498A (en) * 1995-08-17 1999-11-02 Neumann; William L. Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
US6455542B1 (en) * 1998-01-22 2002-09-24 Oxon Medica Inc. Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
US6544975B1 (en) * 1999-01-25 2003-04-08 National Jewish Medical And Research Center Substituted porphyrins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976498A (en) * 1995-08-17 1999-11-02 Neumann; William L. Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
US6455542B1 (en) * 1998-01-22 2002-09-24 Oxon Medica Inc. Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
US6544975B1 (en) * 1999-01-25 2003-04-08 National Jewish Medical And Research Center Substituted porphyrins

Also Published As

Publication number Publication date
WO2006037050A2 (fr) 2006-04-06

Similar Documents

Publication Publication Date Title
WO2008051805A3 (fr) Modulateurs de protéines kinases à base de triazolopyridazines
PL1928499T3 (pl) Zastosowanie inhibitora DPP-IV do ograniczania epizodów hipoglikemii
WO2009111239A3 (fr) Dérivés de pyrrolidine
WO2006127287A3 (fr) Inhibiteurs a base de pyrrolopyridine, pour inhiber la dipeptidyl peptidase iv, et procedes correspondants
WO2007035629A3 (fr) Inhibiteurs de dipeptidylpeptidase
WO2008054585A3 (fr) Utilisation d'il-10 pégilée pour traiter un cancer
WO2006078463A3 (fr) Methode de traitement de maladie cardio-vasculaire
WO2007136759A3 (fr) Procédé de traitement et de prévention de troubles oculaires
WO2008136394A1 (fr) Procédé de production d'un composé de lactame et intermédiaire pour le procédé de production
WO2008051808A3 (fr) Triazoles bicycliques en tant que modulateurs de protéine kinase
WO2011049344A3 (fr) Procédé de préparation de sitagliptine et intermédiaires utilisés dans celui-ci
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2008063932A3 (fr) Procédé pour traiter une dégénérescence maculaire liée à l'âge
WO2009018065A3 (fr) Nouveaux activateurs de glucokinase et procédés pour les utiliser
WO2007018808A3 (fr) Procedes et produits intermediaires pour la synthese de porphyrines
WO2008039941A3 (fr) Protéine scgb3a2 utilisée en tant que facteur de croissance et qu'agent anti-apoptotique
WO2008002614A3 (fr) Nitrones de pseudoazulényle
WO2006118973A3 (fr) Procedes d'utilisation de composes heterocycliques [3.2.0] et de leurs analogues
WO2011001111A3 (fr) Utilisation d'un composé d'acide jasmonique pour traiter la peau grasse
WO2006037050A3 (fr) Procedes pour traiter l'insuffisance cardiaque congestive
WO2010039920A3 (fr) Composés à base de boldine pour favoriser la croissance osseuse
WO2010025135A3 (fr) Dérivés de triméprazine et d’éthopropazine pour favoriser la croissance osseuse
WO2009029836A3 (fr) Thérapie par nitrite et nitrite-méthène pour détoxifier des substituts sanguins à base d'hémoglobine exempte de stroma
WO2007149305A3 (fr) Procédé d'oxydation amélioré présentant une meilleure sécurité, utile dans la fabrication de moxidectine
WO2005117913A3 (fr) Composition pharmaceutique ozonisee et procede associe

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase